首页> 外文期刊>JMIR Medical Informatics >Patient-Sharing Relations in the Treatment of Diabetes and Their Implications for Health Information Exchange: Claims-Based Analysis
【24h】

Patient-Sharing Relations in the Treatment of Diabetes and Their Implications for Health Information Exchange: Claims-Based Analysis

机译:糖尿病患者中的患者共享关系及其对健康信息交换的影响:基于索赔的分析

获取原文
           

摘要

Background Health information exchange (HIE) among care providers who cooperate in the treatment of patients with diabetes mellitus (DM) has been rated as an important aspect of successful care. Patient-sharing relations among care providers permit inferences about corresponding information-sharing relations. Objectives This study aimed to obtain information for an effective HIE platform design to be used in DM care by analyzing patient-sharing relations among various types of care providers (ToCPs), such as hospitals, pharmacies, and different outpatient specialists, within a nationwide claims dataset of Austrian DM patients. We focus on 2 parameters derived from patient-sharing networks: (1) the principal HIE partners of the different ToCPs involved in the treatment of DM and (2) the required participation rate of ToCPs in HIE platforms for the purpose of effective communication. Methods The claims data of 7.9 million Austrian patients from 2006 to 2007 served as our data source. DM patients were identified by their medication. We established metrics for the quantification of our 2 parameters of interest. The principal HIE partners were derived from the portions of a care provider’s patient-sharing relations with different ToCPs. For the required participation rate of ToCPs in an HIE platform, we determine the concentration of patient-sharing relations among ToCPs. Our corresponding metrics are derived in analogy from existing work for the quantification of the continuity of care. Results We identified 324,703 DM patients treated by 12,226 care providers; the latter were members of 16 ToCPs. On the basis of their score for 2 of our parameters, we categorized the ToCPs into low , medium , and high . For the most important HIE partner parameter, pharmacies, general practitioners (GPs), and laboratories were the representatives of the top group, that is, our care providers shared the highest numbers of DM patients with these ToCPs. For the required participation rate of type of care provide (ToCP) in HIE platform parameter, the concentration of DM patient-sharing relations with a ToCP tended to be inversely related to the ToCPs member count. Conclusions We conclude that GPs, pharmacies, and laboratories should be core members of any HIE platform that supports DM care, as they are the most important DM patient-sharing partners. We further conclude that, for implementing HIE with ToCPs who have many members (in Austria, particularly GPs and pharmacies), an HIE solution with high participation rates from these ToCPs (ideally a nationwide HIE platform with obligatory participation of the concerned ToCPs) seems essential. This will raise the probability of HIE being achieved with any care provider of these ToCPs. As chronic diseases are rising because of aging societies, we believe that our quantification of HIE requirements in the treatment of DM can provide valuable insights for many industrial countries.
机译:背景技术在治疗糖尿病患者(DM)方面合作的护理提供者之间的健康信息交换(HIE)被认为是成功护理的重要方面。护理提供者之间的患者共享关系允许推断相应的信息共享关系。目的本研究旨在通过分析全国范围内各种类型的护理提供者(ToCP),如医院,药房和不同的门诊专家之间的患者共享关系,来获得用于DM护理的有效HIE平台设计的信息。奥地利DM患者的数据集。我们关注从患者共享网络得出的两个参数:(1)参与DM治疗的不同ToCP的主要HIE伙伴,以及(2)为了有效沟通的目的,ToCP在HIE平台中的参与率。方法将2006年至2007年的790万奥地利患者的理赔数据作为我们的数据来源。 DM患者通过他们的药物识别。我们建立了量化指标来量化我们感兴趣的两个参数。 HIE的主要合作伙伴来自护理提供者与不同ToCP的患者共享关系中的部分。对于在HIE平台中ToCP的要求参与率,我们确定ToCP之间患者共享关系的集中程度。类似地,我们的相应指标是从现有工作中得出的,用于量化护理的连续性。结果我们确定了324,703名DM患者,这些患者由12,226名护理提供者治疗;后者是16个ToCP的成员。根据他们对我们两个参数的得分,我们将ToCP分为低,中和高。对于最重要的HIE合作伙伴参数,药房,全科医生(GPs)和实验室是最高群体的代表,也就是说,我们的护理提供者与这些ToCP共享的DM患者最多。对于HIE平台参数中所需的护理类型提供(ToCP)参与率,与ToCP的DM患者共享关系的集中度倾向于与ToCP成员数成反比。结论我们得出的结论是,全科医生,药房和实验室应该是任何支持DM护理的HIE平台的核心成员,因为它们是DM患者共享的最重要合作伙伴。我们进一步得出结论,对于与拥有许多成员的ToCP实施HIE(在奥地利,尤其是全科医生和药房),这些ToCP参与率高的HIE解决方案(理想的是全国性的HIE平台,相关ToCP必须参与)是必不可少的。 。这将增加这些ToCP的任何护理提供者实现HIE的可能性。随着社会的衰老,慢性病在增加,我们相信,对DM治疗中HIE需求的量化可以为许多工业国家提供有价值的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号